Collagen is the most abundant protein in the human body, providing structure to skin, bones, tendons, and cartilage — a biological fact known for well over a century, though the modern supplement industry built around ingestible collagen is a comparatively recent development, expanding rapidly over the past two decades as hydrolyzed collagen powders became widely commercially available.
Collagen's inclusion in this Atlas reflects a now-familiar pattern: genuine, well-established biology, paired with a marketing reputation that has, in at least one important respect, outpaced independently-verified evidence.
Collagen supplementation has genuinely useful evidence in one specific area: joint health. A comprehensive 2026 umbrella review — covering 113 randomized controlled trials and nearly 8,000 participants — found consistent, clinically meaningful improvements in osteoarthritis pain and stiffness, alongside benefits for skin hydration and elasticity.
The genuinely important caveat concerns skin-specific claims, collagen's most heavily marketed use: a rigorous 2025 meta-analysis of 23 RCTs (1,474 participants) found a striking funding-bias pattern — studies funded by pharmaceutical or collagen companies showed significant skin benefits, while independently-funded studies found no significant effect, and high-quality studies specifically found no significant effect. This is a real, quantified funding-bias signal worth knowing. Given genuine joint-health benefit but a documented funding-bias problem undermining the skin claims, "Limited-Moderate" is the honest, appropriately weighted rating.
Not applicable in the traditional herbal sense — modern supplements are manufactured by breaking down animal-derived collagen into more easily absorbed peptides.